ARCA biopharma, Inc. - FORM 10-Q/A - EX-31.2 - SECTION 302 CFO CERTIFICATION - November 6, 2009

Attached files

file filename
10-Q/A - FORM 10-Q AMENDMENT NO. 1 - ARCA biopharma, Inc.d10qa.htm
EX-10.2 - AMENDMENT TO LICENSE AND SUBLICENSE AGREEMENT - ARCA biopharma, Inc.dex102.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - ARCA biopharma, Inc.dex311.htm
EX-10.11 - DEVELOPMENT, COMMERCIALIZATION AND LICENSING AGREEMENT - ARCA biopharma, Inc.dex1011.htm

Exhibit 31.2

CERTIFICATION

I, Kathryn E. Falberg, certify that:

1. I have reviewed this quarterly report on Form 10-Q/A of ARCA biopharma, Inc.; and

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: November 6, 2009

 

/s/ Kathryn E. Falberg

Kathryn E. Falberg
Chief Financial Officer and Chief Operating Officer

ARCA biopharma, Inc. Reports